Between 2013 and 2023, the tuberculosis treatment success rate for newly treated cases in Indonesia decreased from 88 to 82 units. In 2023, it stood at 82 units. Over the last two years, the year-on-year variations have been relatively stable, with the treatment success rate remaining at 82 units in 2022 and 2023. The 5-year compound annual growth rate (CAGR) forecast from 2024 to 2028 is -0.25%, indicating a gradual decline. The overall 5-year growth rate is projected at -1.22%, suggesting a continuous decrease in treatment success effectiveness.
Looking forward, key trends to monitor include potential improvements in healthcare infrastructure, innovative treatment options, and effective public health interventions. Monitoring these factors will be critical for understanding the future trajectory of tuberculosis treatment success in Indonesia.
